Tag: NTI drugs

Learn how prior authorization affects NTI drugs, why insurers require brands, and strategies to avoid dangerous delays for medications like levothyroxine and phenytoin.

Switching to generic NTI drugs requires clear, specific communication to ensure patient safety. Learn what to say, what to monitor, and how to build trust when substituting critical medications like warfarin, levothyroxine, and phenytoin.

Prescribers remain cautious about substituting generic drugs for narrow therapeutic index (NTI) medications due to risks of therapeutic failure or toxicity. Despite FDA assurances, many doctors prefer brand-name NTI drugs for stability, especially with warfarin, levothyroxine, and tacrolimus. State laws, communication gaps, and real-world errors fuel ongoing debate.